组织蛋白酶S与慢阻肺肺功能及CT表型的关联
该研究纳入46例稳定期慢阻肺患者和29名健康对照,检测BALF中组织蛋白酶S和IFN-γ水平,并用HRCT测量LAA%、2T/D和WA。结果显示组织蛋白酶S水平随GOLD分级和LAA分级升高而升高,与FEV1/FVC、FEV1%pred、DLCO%pred负相关,与RV/TLC%、LAA%、2T/D、WA和IFN-γ正相关。
要点
- BALF组织蛋白酶S水平随慢阻肺GOLD分级升高而升高。
- 组织蛋白酶S与气流受限指标负相关,与肺气肿和气道壁指标正相关。
- 组织蛋白酶S可能通过γ-干扰素参与慢阻肺发病机制。
核心结论
- 慢阻肺患者BALF中组织蛋白酶S水平与气流受限程度及肺气肿表型相关。
研究设计与样本
- 研究纳入2014年4月至2017年4月稳定期慢阻肺患者46例,按GOLD分级分为Ⅰ级12例、Ⅱ级6例、Ⅲ级14例、Ⅳ级14例,另设健康对照组29名。
- 采用ELISA测定BALF中组织蛋白酶S和γ-干扰素水平,用HRCT测量LAA%、2T/D和WA。
主要发现
- 对照组、GOLD Ⅰ、Ⅱ、Ⅲ、Ⅳ级患者BALF组织蛋白酶S水平分别为(0.5±0.3)、(2.3±0.9)、(3.1±1.2)、(4.3±1.5)和(5.5±1.7)μg/L,各组间差异有统计学意义(F=6.639,P=0.000)。
- 组织蛋白酶S水平为GOLD Ⅳ组>GOLD Ⅲ组>GOLD Ⅱ组>GOLD Ⅰ组>健康对照组(均P<0.05),LAA 3级>LAA 2级>LAA 1级>LAA 0级(均P<0.01)。
- 组织蛋白酶S与FEV1/FVC、FEV1占预计值%、DLCO占预计值%呈显著负相关(均P<0.05),与RV/TLC%、LAA%、2T/D、WA和γ-干扰素呈显著正相关(均P<0.05)。
临床怎么用
- BALF组织蛋白酶S或可作为评估慢阻肺气流受限程度和肺气肿表型的生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore the value of cathepsin S in the bronchoalveolar lavage fluid (BALF) of patients with chronic obstructive pulmonary disease (COPD) in the evaluation of pulmonary function and CT phenotypes. Method: From April 2014 to April 2017, 46 patients with stable COPD were enrolled, and 29 healthy volunteers served as the control group. The patients were divided into 4 subgroups: GOLD Ⅰ(n=12), GOLD Ⅱ(n=6), GOLD Ⅲ(n=14), GOLD Ⅳ(n=14). The levels of cathepsin S and IFN-γ in BALF were determined by enzyme-linked immunosorbent assay (ELISA). The percentage ratio of low attenuation area to total lung area (LAA%), two times the ratio of airway wall thickness to outer diameter(2T/D), and the ratio of wall area to total cross-sectional area (WA) were measured by HRCT. Results: There were significant differences in the levels of cathepsin S in BALF between the groups (F=6.639, P=0.000). BALF cathepsin S levels were as follows: GOLD Ⅳ grou P>GOLD Ⅲ grou P>GOLD Ⅱ grou P>GOLD group Ⅰ >healthy control group (P value were all<0.05); LAA grade 3>LAA grade 2>LAA grade 1>LAA grade 0 (P value were all<0.05). Correlation analysis showed that BALF cathepsin S levels were correlated negatively with FEV(1)/FVC, FEV(1)% predicted, and DLCO% (r value was -0.065、-0.576、-0.392, respectively, P value were all<0.05), and but positively with RV/TLC%, LAA%, 2T/D, WA and IFN-γ(r value was 0.695, 0.497, 0.142, 0.309, 0.148, respectively, P value were all<0.05). Conclusion: The levels of cathepsin S were associated with the degree of airflow limitation and emphysema phenotype in COPD. 目的: 探讨慢性阻塞性肺疾病(慢阻肺)患者BALF中组织蛋白酶S在评估肺功能及CT表型中的价值。 方法: 纳入2014年4月至2017年4月在上海市第六人民医院东院呼吸内科收治的慢阻肺稳定期患者46例,按GOLD分级分为Ⅰ级12例、Ⅱ级6例、Ⅲ级14例以及Ⅳ级14例。同期以胸痛伴慢性咳嗽或声音嘶哑为自觉症状在我院自愿进行纤维支气管镜及BALF检查,经各项检查证实为健康者29名,作为对照组。酶联免疫吸附测定法(ELISA)测定BALF中组织蛋白酶S和γ-干扰素的水平。高分辨率CT测量低衰减区域(LAA)占全肺体积的百分比(LAA%)、2倍气道壁厚度与气道直径比(2T/D)、管壁面积占总横截面积比(WA)。 结果: 对照组、GOLD Ⅰ、Ⅱ、Ⅲ、Ⅳ级患者BALF中组织蛋白酶水平分别为(0.5±0.3)、(2.3±0.9)、(3.1±1.2)、(4.3±1.5)和(5.5±1.7)μg/L,各组间差异有统计学意义(F=6.639,P=0.000);各组组织蛋白酶S水平为GOLD Ⅳ组>GOLD Ⅲ组>GOLD Ⅱ组>GOLD Ⅰ组>健康对照组(均P<0.05);LAA 3级>LAA 2级>LAA 1级>LAA 0级(均P<0.01);组织蛋白酶S与FEV(1)/FVC、FEV(1)占预计值%、D(L)CO占预计值%呈显著负相关(均P<0.05),与RV/TLC%、LAA%、2T/D、WA和γ-干扰素呈显著正相关(均P<0.05)。 结论: 组织蛋白酶S水平反映慢阻肺气流受限程度及肺气肿表型,并可能通过γ-干扰素参与到慢阻肺肺气肿和气流受限的发病机制中。.
引用
- Wu KY, Zhu Z, Wang Y, et al. [The association between Cathepsin S and pulmonary function and CT phenotypes in patients with chronic obstructive pulmonary disease]. Zhonghua Jie He He Hu Xi Za Zhi. 2019. PMID: 31137114. doi:10.3760/cma.j.issn.1001-0939.2019.05.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。